Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects
Clinical trial NCT01449929 · COMPLETED
Trial details
- NCT number
- NCT01449929
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-31
- Primary completion
- 2013-04-22
- Enrollment
- 488
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.